Acute myeloid leukemia - benzene sunscreen claims

As a cancer of the bone marrow and blood, acute myeloid leukemia occurs in over 20,000 people in the U.S. at the moment, which makes it a quite rare disease. While acute myeloid leukemia mostly occurs in adults, it is also the second most common type of leukemia diagnosed in children. Sadly, the five-year survival rate for acute myeloid leukemia is only 24%, making the prognosis of this cancer very poor. One of the risk factors for acute myeloid leukemia is frequent benzene exposure, which can occur by regularly applying tainted sunscreen. According to the Department of Health and Human Services, long-term exposure to high concentrations of benzene from the air can cause leukemia. Most problematic sunscreen concerned aerosol products, which means that consumers were significantly exposed through inhalation to the chemical. If you have acute myeloid leukemia and have been using one of the contaminated sunscreen products, we encourage you to contact us, as you might be entitled to financial compensation.

Claim Application

Acute myeloid leukemia develops when the bone marrow produces a large number of abnormal blood cells. It can take a toll on red blood cells, white blood cells, and platelets. While acute myeloid leukemia is a type of leukemia, it also has subtypes – eight, to be more specific - which are:

  • myeloblastic on special analysis
  • myeloblastic without maturation
  • myeloblastic with maturation
  • promyelocytic
  • myelomonocytic
  • monocytic
  • erythroleukemia
  • megakaryocytic

The most prevalent symptoms of acute myeloid leukemia include frequent infections and fever, anemia, joint pain, easy bleeding or bruising, fatigue, and bone pain. Unfortunately, acute myeloid leukemia typically worsens rapidly if the patient does not receive effective treatment. The disease is also medically known as acute myelogenous leukemia or acute nonlymphocytic leukemia.

Usually, the bone marrow releases blood stem cells, which are immature but become mature over time. A stem cell can become a myeloid or a lymphoid stem cell. While a lymphoid stem cell becomes a white blood cell, a myeloid stem cell becomes one of these kinds of mature blood cells:

  • red blood cell that carries oxygen and other substances to all tissues of the body
  • white blood cell that fights infection and disease
  • platelet that forms blood clots to stop bleeding

When a person has acute myeloid leukemia, the myeloid stem cells become a type of immature white blood cell known as myeloblasts. They are abnormal and do not turn into healthy white blood cells. Sometimes, too many stem cells become abnormal red blood cells or platelets. These are also known as leukemia blasts. Leukemia cells can accumulate in the bone marrow and blood, which allows less space for healthy white and red blood cells and platelets. When this occurs, infection, anemia, or easy bleeding are more likely to affect the person.

The connection between exposure to benzene and acute myeloid leukemia

In our country, benzene ranks among the top 20 chemicals in production volume, according to the Centers for Disease Control and Prevention. Benzene exposure is one of the official risk factors for acute myeloid leukemia, and prolonged contact with the chemical has been known for over a century to damage the bone marrow, resulting in decreases in the numbers of circulating blood cells. Interestingly, benzene exposure can also lead to the development of myelodysplasia, a pre-leukemic state. Leukemia is the most serious, long-term health risk of benzene exposure, regardless of the disease's type.

The theory that benzene exposure could result in leukemia was more challenging and difficult to establish than the demonstration that benzene exposure could induce aplastic anemia. Decreases in blood cells stemming from benzene exposure can be observed a few months after the first contact with the chemical. However, there is a lag time of perhaps years between the initial benzene exposure and the occurrence of leukemia. Medical studies found that even low benzene exposure can increase leukemia risk, which is why people who have been using adulterated sunscreen need to keep a close eye on their health.

Our resourceful attorneys will help you file your benzene sunscreen claim

If you have been applying sunscreen tainted with benzene for at least 5 years and for at least 50 days during each year and subsequently developed acute myeloid leukemia, we highly advise you to contact us, as we specialize in toxic exposure. Our skilled attorneys have over 25 years of professional experience and can efficiently help you recover the financial compensation you are eligible for from the liable company. After you give us a call, you will only have to describe your situation and send our legal experts proof of your disease.

We will rigorously assess your case, and if we determine that you qualify for filing a benzene sunscreen claim, our lawyers will quickly begin preparing it for submission. Until resolution, you can go on with your life, as usual, focusing on your health and treatment, as we will do the hard work for you. We are aware that cancer patients usually need more time to look after themselves and undergo treatment, which is why your involvement will only be necessary during the first steps of the process. Eventually, you will get the money you deserve from the culpable party.